Literature DB >> 33716457

Prognostic Effect of Restoring Sinus Rhythm in Patients with New-Onset Atrial Fibrillation during Acute Coronary Syndrome.

Kuan-Jen Su1,2, Wen-Yu Lin1, Wei-Shiang Lin1, Chin-Sheng Lin1, Cheng-Chung Cheng1, Jun-Ting Liou1, Chen-Hsuan Ho3, Shih-Ping Yang1, Shu-Meng Cheng1, Yuan Hung1.   

Abstract

BACKGROUND: New-onset atrial fibrillation (NOAF) in acute coronary syndrome (ACS) may be associated with a poor prognosis. However, whether restoring sinus rhythm (SR) at discharge in patients with ACS improves outcomes remains unknown.
METHODS: A total of 552 patients with ACS at an emergency department during 2011-2016 were enrolled. According to documented electrocardiography at admission and medical records, the patients were classified into without atrial fibrillation (WAF), NOAF, and prior atrial fibrillation (PAF) groups. Major adverse events (MAEs) were defined as cardiac death, recurrent myocardial infarction, heart failure requiring hospitalization, target lesion revascularization, and stroke. The mean follow-up period of MAEs was 25 ± 15 months.
RESULTS: Compared with the NOAF and PAF groups, the WAF group was younger and had a significantly lower heart rate, prior stroke rate, CHA2DS2-VASc score, and lower Global Registry of Acute Coronary Events (GRACE) score in the emergency department (p < 0.001). The patients in the NOAF group had the highest incidence of MAEs (p < 0.001) during follow-up, and those whose SR was restored at discharge had a lower MAE rate than those with AF at discharge (p = 0.001). In multivariable analysis, prior myocardial infarction, GRACE score, use of beta-blockers, and restoring SR at discharge were independent predictors of MAEs in the NOAF group.
CONCLUSIONS: The patients with ACS who presented with NOAF had worse outcomes than those with PAF or WAF. The patients with NOAF whose rhythm was restored to SR at discharge were associated with better outcomes than those with AF at discharge.

Entities:  

Keywords:  Acute coronary syndrome; Atrial fibrillation; Major adverse events; Myocardial infarction

Year:  2021        PMID: 33716457      PMCID: PMC7953126          DOI: 10.6515/ACS.202103_37(2).20200915A

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


  47 in total

1.  Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes.

Authors:  S S Rathore; A K Berger; K P Weinfurt; K A Schulman; W J Oetgen; B J Gersh; A J Solomon
Journal:  Circulation       Date:  2000-03-07       Impact factor: 29.690

Review 2.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2014-03-28       Impact factor: 24.094

3.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

Authors:  Paulus Kirchhof; Stefano Benussi; Dipak Kotecha; Anders Ahlsson; Dan Atar; Barbara Casadei; Manuel Castella; Hans-Christoph Diener; Hein Heidbuchel; Jeroen Hendriks; Gerhard Hindricks; Antonis S Manolis; Jonas Oldgren; Bogdan Alexandru Popescu; Ulrich Schotten; Bart Van Putte; Panagiotis Vardas; Stefan Agewall; John Camm; Gonzalo Baron Esquivias; Werner Budts; Scipione Carerj; Filip Casselman; Antonio Coca; Raffaele De Caterina; Spiridon Deftereos; Dobromir Dobrev; José M Ferro; Gerasimos Filippatos; Donna Fitzsimons; Bulent Gorenek; Maxine Guenoun; Stefan H Hohnloser; Philippe Kolh; Gregory Y H Lip; Athanasios Manolis; John McMurray; Piotr Ponikowski; Raphael Rosenhek; Frank Ruschitzka; Irina Savelieva; Sanjay Sharma; Piotr Suwalski; Juan Luis Tamargo; Clare J Taylor; Isabelle C Van Gelder; Adriaan A Voors; Stephan Windecker; Jose Luis Zamorano; Katja Zeppenfeld
Journal:  Europace       Date:  2016-08-27       Impact factor: 5.214

4.  Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction.

Authors:  Lars Køber; Karl Swedberg; John J V McMurray; Marc A Pfeffer; Eric J Velazquez; Rafael Diaz; Aldo P Maggioni; Viatcheslav Mareev; Grzegorz Opolski; Frans Van de Werf; Faiez Zannad; Georg Ertl; Scott D Solomon; Steven Zelenkofske; Jean-Lucien Rouleau; Jeffrey D Leimberger; Robert M Califf
Journal:  Eur J Heart Fail       Date:  2006-02-28       Impact factor: 15.534

5.  The significance of new onset atrial fibrillation complicating acute myocardial infarction.

Authors:  Oren Zusman; Guy Amit; Harel Gilutz; Doron Zahger
Journal:  Clin Res Cardiol       Date:  2011-09-11       Impact factor: 5.460

Review 6.  Atrial Fibrillation in Acute Coronary Syndrome.

Authors:  Jason C Rubenstein; Michael P Cinquegrani; Jennifer Wright
Journal:  J Atr Fibrillation       Date:  2012-06-15

7.  Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial.

Authors:  Kent R Nilsson; Sana M Al-Khatib; Yi Zhou; Karen Pieper; Harvey D White; Aldo P Maggioni; Lars Kober; Christopher B Granger; Eldrin F Lewis; John J V McMurray; Robert M Califf; Eric J Velazquez
Journal:  Heart       Date:  2010-04-20       Impact factor: 5.994

8.  Temporal trends and outcomes associated with atrial fibrillation observed during acute coronary syndrome: Real-world data from the Acute Coronary Syndrome Israeli Survey (ACSIS), 2000-2013.

Authors:  Aharon Erez; Ilan Goldenberg; Avi Sabbag; Eyal Nof; Doron Zahger; Shaul Atar; Arthur Pollak; Idit Dobrecky-Merye; Roy Beigel; Shlomi Matetzky; Michael Glikson; Roy Beinart
Journal:  Clin Cardiol       Date:  2016-12-05       Impact factor: 2.882

9.  Effect of acute atrial fibrillation on phasic coronary blood flow pattern and flow reserve in humans.

Authors:  G E Kochiadakis; E I Skalidis; M D Kalebubas; N E Igoumenidis; S I Chrysostomakis; E M Kanoupakis; E N Simantirakis; P E Vardas
Journal:  Eur Heart J       Date:  2002-05       Impact factor: 29.983

Review 10.  Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications.

Authors:  Joern Schmitt; Gabor Duray; Bernard J Gersh; Stefan H Hohnloser
Journal:  Eur Heart J       Date:  2008-12-24       Impact factor: 29.983

View more
  1 in total

1.  Newly Diagnosed Atrial Fibrillation in Acute Myocardial Infarction.

Authors:  Yuki Obayashi; Hiroki Shiomi; Takeshi Morimoto; Yodo Tamaki; Moriaki Inoko; Ko Yamamoto; Yasuaki Takeji; Tomohisa Tada; Kazuya Nagao; Kyohei Yamaji; Kazuhisa Kaneda; Satoru Suwa; Toshihiro Tamura; Hiroki Sakamoto; Tsukasa Inada; Mitsuo Matsuda; Yukihito Sato; Yutaka Furukawa; Kenji Ando; Kazushige Kadota; Yoshihisa Nakagawa; Takeshi Kimura
Journal:  J Am Heart Assoc       Date:  2021-09-17       Impact factor: 5.501

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.